adenosine diphosphate has been researched along with Arterial Obstructive Diseases in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (48.48) | 18.7374 |
| 1990's | 6 (18.18) | 18.2507 |
| 2000's | 9 (27.27) | 29.6817 |
| 2010's | 2 (6.06) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jakubowski, JA; Mizuno, M; Ohno, K; Sugidachi, A; Tomizawa, A | 1 |
| Chepurko, E; Covarrubias, R; Cowan, PJ; Dwyer, KM; Gumina, RJ; Huttinger, R; Huttinger, ZM; Novitskaya, T; Reynolds, A; Robson, SC; Stanfill, K; Wheeler, DG | 1 |
| Cazenave, JP; Gachet, C; Lanza, F; Wiesel, ML | 1 |
| Erl, W; Gachet, C; Haserück, N; Ohlmann, P; Pandey, D; Ravanat, C; Siess, W; Tigyi, G | 1 |
| Humphries, RG; van Giezen, JJ | 1 |
| Harder, S; Klinkhardt, U | 1 |
| Iwatani, Y; Kanakura, Y; Kuratsune, H; Nojima, J; Suehisa, E | 1 |
| Benner, KU; Burstedde, V; Everts, B; Geeren, M | 1 |
| Andries, R; Bourgain, RH; Deby, C; Deby-Dupont, G | 1 |
| Allison, TB; Holsinger, JW | 1 |
| Angelkort, B; Kiesewetter, H | 1 |
| Abe, T; Maki, Y; Nose, T; Tanoue, K | 1 |
| Bozarth, JM; Diemer, M; Forsythe, MS; Mousa, SA; Reilly, TM | 1 |
| Capecchi, PL; Chiavetta, M; De Lalla, A; Di Perri, T; Laghi Pasini, F; Sensi, S; Sodi, N; Volpi, L | 1 |
| Hirata, Y; Nakano, M; Nakashima, M; Uematsu, T; Umemura, K | 1 |
| Andries, R; Boichot-Lagente, E; Bourgain, RH; Decuyper, K; Paubert-Braquet, M; Shen, S | 1 |
| Gardner, AW; Sieminski, DJ | 1 |
| Fiore, L; Hasbargen, JA; Kaufman, JS; O'Connor, TZ; Perdriset, G | 1 |
| Driscoll, EM; Gonzales, ML; Huang, J; Lucchesi, BR; Park, AM | 1 |
| Goto, S; Handa, M; Ikeda, Y; Murata, M | 1 |
| Koksch, M; Pfeiffer, D; Ruehlmann, C; Woinke, M; Zeiger, F | 1 |
| Aamodt, R; Capurro, NL; Epstein, SE; Goldstein, RE; Marr, KC | 1 |
| Morris-Jones, W; Porter, N; Preston, FE; Ward, AS | 1 |
| Chiu, CJ; Hinchey, EJ; Modry, DL | 1 |
| Ault, KA; Cronenwett, JL; Galt, SW; McDaniel, MD; Mitchell, J | 1 |
| Bull, H; Machin, SJ; Mackie, IJ; Yardumian, DA | 1 |
| Higuchi, M; Kakishita, E; Nagai, K; Suehiro, A | 1 |
| Eklöf, B; Jabs, CM; Neglén, P | 1 |
| Zahavi, J; Zahavi, M | 1 |
| Klieber, M; Niessner, H; Siostrzonek, P | 1 |
| Hoak, JC; Wu, KK | 1 |
| Oski, FA; Stockman, JA; Stuart, MJ | 1 |
| Bousser, MG; Lecrubier, C | 1 |
2 review(s) available for adenosine diphosphate and Arterial Obstructive Diseases
| Article | Year |
|---|---|
Preclinical and clinical studies with selective reversible direct P2Y12 antagonists.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Administration, Oral; Animals; Arterial Occlusive Diseases; Clinical Trials as Topic; Dogs; Double-Blind Method; Drug Evaluation, Preclinical; Female; Fibrinolytic Agents; Humans; Injections, Intravenous; Male; Membrane Proteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Pyridines; Rabbits; Randomized Controlled Trials as Topic; Receptors, Purinergic P2Y12; Thrombosis; Ticagrelor | 2005 |
A new approach to antiplatelet therapy: inhibitor of GPIb/V/IX-vWF interaction.
Topics: Acetates; Adenosine Diphosphate; Animals; Antibodies, Monoclonal; Arterial Occlusive Diseases; Collagen; Drug Evaluation, Preclinical; Epinephrine; Epitopes; Genetic Predisposition to Disease; Guinea Pigs; Hemorheology; Humans; Integrins; Liposomes; Macromolecular Substances; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Polymorphism, Genetic; Receptors, Collagen; Recombinant Fusion Proteins; Stress, Mechanical; Thrombosis; Tyrosine; von Willebrand Factor | 2000 |
2 trial(s) available for adenosine diphosphate and Arterial Obstructive Diseases
| Article | Year |
|---|---|
Increase in plasma levels of adenosine and adenine nucleotides after intravenous infusion of buflomedil in humans.
Topics: Adenine Nucleotides; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Aged; Analysis of Variance; Arterial Occlusive Diseases; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pyrrolidines; Vasodilator Agents | 1995 |
Changes in signal transduction in the platelets of patients with peripheral occlusive arterial disease.
Topics: Adenosine Diphosphate; Arterial Occlusive Diseases; Blood Platelets; Colforsin; Enzyme Inhibitors; Estrenes; Female; Flow Cytometry; Humans; In Vitro Techniques; Indoles; Male; Maleimides; Middle Aged; P-Selectin; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Proteins; Pyrrolidinones; Receptors, Thrombin; Second Messenger Systems; Signal Transduction | 2000 |
29 other study(ies) available for adenosine diphosphate and Arterial Obstructive Diseases
| Article | Year |
|---|---|
Prevention of occlusive arterial thrombus formation by a single loading dose of prasugrel suppresses neointimal hyperplasia in mice.
Topics: Adenosine Diphosphate; Animals; Aorta; Arterial Occlusive Diseases; Arteries; Carotid Arteries; Chemokine CCL2; Chlorides; Ferric Compounds; Hyperplasia; Inflammation; Intercellular Adhesion Molecule-1; Mice; Mice, Inbred C57BL; Neointima; Platelet Aggregation; Prasugrel Hydrochloride; Pyridines; RNA, Messenger; Thrombosis; Time Factors; Transforming Growth Factor beta1 | 2015 |
Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Antigens, CD; Apyrase; Arterial Occlusive Diseases; Blood Coagulation; Bone Marrow Transplantation; Chlorides; Disease Models, Animal; Endothelial Cells; Ferric Compounds; Genetic Predisposition to Disease; HEK293 Cells; Humans; Hydrolysis; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Monocytes; Phenotype; Platelet Activation; Thrombosis; Time Factors; Transfection | 2016 |
[Platelets and arterial thrombosis].
Topics: Adenosine Diphosphate; Angioplasty, Balloon; Anti-Bacterial Agents; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Blood Platelets; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Thrombin; Thrombosis | 2003 |
The plaque lipid lysophosphatidic acid stimulates platelet activation and platelet-monocyte aggregate formation in whole blood: involvement of P2Y1 and P2Y12 receptors.
Topics: Adenosine Diphosphate; Arterial Occlusive Diseases; Blood Platelets; Cell Size; Humans; Kinetics; Lysophospholipids; Membrane Proteins; Platelet Activation; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Signal Transduction | 2004 |
Flow cytometric measurement of platelet-leukocyte aggregates: a possible target to monitor platelet function?
Topics: Adenosine Diphosphate; Adult; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Clopidogrel; Flow Cytometry; Heart Diseases; Humans; Leukocytes; Male; Monocytes; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Risk; Ticlopidine | 2005 |
The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus.
Topics: Abortion, Habitual; Adenosine Diphosphate; Adolescent; Adult; Aged; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Arterial Occlusive Diseases; Autoantibodies; Autoantigens; beta 2-Glycoprotein I; Child; Enzyme-Linked Immunosorbent Assay; Female; Glycoproteins; Humans; Immunoglobulin G; Lupus Erythematosus, Systemic; Male; Middle Aged; Phosphatidylserines; Platelet Activation; Pregnancy; Prothrombin; Risk Factors; Thrombophilia; Venous Thrombosis | 2006 |
Platelet aggregation abnormalities in arterial occlusive diseases (AOD).
Topics: Adenosine Diphosphate; Arterial Occlusive Diseases; Female; Humans; Male; Nephelometry and Turbidimetry; Platelet Aggregation; Platelet Count; Thrombophlebitis | 1984 |
Enhancement of arterial thromboformation by uric acid, a free radical scavenger.
Topics: Adenosine Diphosphate; Animals; Arterial Occlusive Diseases; Epoprostenol; Free Radicals; Photometry; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred Strains; Thrombosis; Thromboxane A2; Tranylcypromine; Uric Acid | 1982 |
Myocardial metabolism and regional myocardial blood flow in the canine left ventricle following twenty minutes of circumflex artery occlusion and reperfusion.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Arterial Occlusive Diseases; Coronary Circulation; Coronary Disease; Dogs; Endocardium; Glucose-6-Phosphate; Glucosephosphates; Heart Ventricles; Hyperemia; Myocardium; Phosphocreatine | 1983 |
Influence of risk factors and coagulation phenomena on the fluidity of blood in chronic arterial occlusive disease.
Topics: Adenosine Diphosphate; Arterial Occlusive Diseases; Blood Coagulation; Blood Flow Velocity; Chronic Disease; Collagen; Humans; Hypercholesterolemia; Male; Microcirculation; Pentoxifylline; Platelet Aggregation; Platelet Factor 3; Risk; Smoking; Theobromine; Triglycerides | 1981 |
Platelet aggregation in patients with Moyamoya disease.
Topics: Adenosine Diphosphate; Adolescent; Adult; Arterial Occlusive Diseases; Child; Child, Preschool; Epinephrine; Female; Humans; Male; Middle Aged; Moyamoya Disease; Platelet Aggregation | 1981 |
Thrombolytic and antithrombotic efficacy of the platelet GPIIb-IIIa antagonist DMP728.
Topics: Adenosine Diphosphate; Animals; Arterial Occlusive Diseases; Clinical Protocols; Dogs; Drug Therapy, Combination; Female; Femoral Artery; Fibrinolysis; Hemodynamics; Humans; Male; Mesylates; Models, Cardiovascular; Peptides, Cyclic; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Binding; Recurrence; Streptokinase; Thrombosis | 1994 |
Enhancement of thrombotic arterial occlusion following cholesterol feeding in the guinea-pig: a role for thromboxane A2.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Animals; Arterial Occlusive Diseases; Cholesterol, Dietary; Collagen; Femoral Artery; Guinea Pigs; Male; Photochemistry; Platelet Activating Factor; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Thrombosis; Thromboxane A2; Time Factors | 1994 |
An optoelectronic registration method as applied to PAF-mediated hydrogen peroxide induced arterial thrombosis.
Topics: Adenosine Diphosphate; Animals; Animals, Laboratory; Arterial Occlusive Diseases; Arterioles; Electroshock; Endothelium, Vascular; Guinea Pigs; Hydrogen Peroxide; In Vitro Techniques; Male; Mesenteric Arteries; Platelet Activating Factor; Rats; Rats, Wistar; Thrombosis | 1994 |
The relationship between free-living daily physical activity and the severity of peripheral arterial occlusive disease.
Topics: Adenosine Diphosphate; Aged; Arterial Occlusive Diseases; Exercise; Exercise Test; Exercise Therapy; Female; Humans; Intermittent Claudication; Male; Middle Aged; Monitoring, Ambulatory; Surveys and Questionnaires | 1997 |
A pharmacodynamic study of clopidogrel in chronic hemodialysis patients.
Topics: Adenosine Diphosphate; Arterial Occlusive Diseases; Chronic Disease; Clopidogrel; Dose-Response Relationship, Drug; Hemostasis; Humans; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Renal Dialysis; Renal Insufficiency; Thrombosis; Ticlopidine | 2000 |
Prevention of arterial thrombosis by intravenously administered platelet P2T receptor antagonist AR-C69931MX in a canine model.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Animals; Arterial Occlusive Diseases; Bleeding Time; Blood Flow Velocity; Blood Platelets; Carotid Arteries; Carotid Artery Thrombosis; Disease Models, Animal; Dogs; Female; Hemodynamics; Injections, Intravenous; Male; Membrane Proteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Tunica Intima | 2000 |
Aspirin-induced increase in collateral flow after acute coronary occlusion in dogs.
Topics: Acute Disease; Adenosine Diphosphate; Animals; Arterial Occlusive Diseases; Aspirin; Collateral Circulation; Coronary Vessels; Dogs; Female; Male; Platelet Aggregation; Time Factors | 1979 |
Platelet aggregation in patients with peripheral vascular disease.
Topics: Adenosine Diphosphate; Adult; Aged; Arterial Occlusive Diseases; Epinephrine; Female; Humans; Male; Middle Aged; Platelet Aggregation | 1978 |
The roles of ventilation and perfusion in lung metabolism.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Airway Obstruction; Animals; Arterial Occlusive Diseases; Blood Gas Analysis; Blood Glucose; Dogs; Glycogen; Hypoxia; Lactates; Lung; Postoperative Complications; Pulmonary Artery; Pulmonary Edema; Respiratory Distress Syndrome; Ventilation-Perfusion Ratio | 1977 |
Flow cytometric assessment of platelet function in patients with peripheral arterial occlusive disease.
Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; beta-Thromboglobulin; Blood Platelets; Cell Adhesion Molecules; Dose-Response Relationship, Drug; Female; Flow Cytometry; Humans; Male; Middle Aged; P-Selectin; Peripheral Vascular Diseases; Platelet Aggregation; Platelet Membrane Glycoproteins | 1991 |
Platelet responses observed during and after infusions of the prostacyclin analog ZK 36 374.
Topics: Adenosine Diphosphate; Arterial Occlusive Diseases; Blood Platelets; Cardiovascular Agents; Collagen; Epoprostenol; Fingers; Humans; Iloprost; Ischemia; Male; Middle Aged; Platelet Aggregation; Scleroderma, Systemic; Time Factors | 1985 |
A new index for collagen induced platelet aggregation.
Topics: Adenosine Diphosphate; Animals; Arterial Occlusive Diseases; Blood Platelets; Collagen; Disease Susceptibility; Ellagic Acid; Factor XII; Humans; Platelet Aggregation; Platelet Count; Platelet Function Tests; Rabbits; Thrombosis | 1989 |
Plasma metabolic disturbances and reperfusion injury following partial limb ischaemia in man.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adult; Aged; Arterial Occlusive Diseases; Blood Vessel Prosthesis; Creatine; Creatinine; Female; Free Radicals; Humans; Hypoxanthines; Lactates; Leg; Male; Middle Aged; Phosphocreatine; Reperfusion Injury | 1989 |
Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease.
Topics: Adenosine Diphosphate; Aged; Arterial Occlusive Diseases; beta-Thromboglobulin; Blood Platelets; Cell Survival; Epinephrine; Epoprostenol; Female; Humans; In Vitro Techniques; Male; Middle Aged; Platelet Aggregation; Thromboxane B2; Thromboxanes | 1985 |
[Effect of 24-day exercise therapy on induced thrombocyte aggregation in peripheral arterial occlusive disease in Fontaine stage II].
Topics: Adenosine Diphosphate; Aged; Arterial Occlusive Diseases; Collagen; Diabetes Complications; Exercise Test; Exercise Therapy; Female; Humans; Hypertension; Male; Middle Aged; Platelet Aggregation; Risk; Time Factors | 1985 |
A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency.
Topics: Adenosine Diphosphate; Adolescent; Adult; Angina Pectoris; Animals; Arterial Occlusive Diseases; Arteriosclerosis; Blood Cell Count; Blood Specimen Collection; Cardiovascular Diseases; Formaldehyde; Humans; In Vitro Techniques; Infusions, Parenteral; Ischemic Attack, Transient; Middle Aged; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Rabbits; Thrombin; Thromboembolism | 1974 |
Abnormalities of platelet aggregation in the vaso-occlusive crisis of sickle-cell anemia.
Topics: Adenosine Diphosphate; Anemia, Sickle Cell; Arterial Occlusive Diseases; Bilirubin; Blood; Erythrocytes; Fibrin; Humans; Platelet Adhesiveness; Platelet Aggregation; Veins | 1974 |
[Experimental platelet aggregation and arterial thrombosis. Effect of aspirin].
Topics: Adenosine Diphosphate; Animals; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Collagen; Epinephrine; Humans; In Vitro Techniques; Platelet Adhesiveness; Rabbits; Thrombosis | 1973 |